Medicus Pharma Ltd's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medicus Pharma Ltd's ROI in the second quarter of 2026?
Medicus Pharma Ltd recorded a cumulative net loss of $-45 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -1025.95%.

Within the Healthcare sector 786 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3859 to 4430.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	72.2 %	-31.82 %	20.52 %	662.83 %	-
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	16	2	0	-1	3
Return On Investment (TTM)	-1025.95 %	-3410.99 %	-2642.37 %	-	-672.69 %
MDCX's Overall Ranking	# 4430	# 3859	# 3815	# 0	# 0
Seq. Investment Change TTM	278.97 %	-13.92 %	-36.71 %	-16.59 %	50.05 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-45	-39	-35	-31	-17

MDCX Company Profile >> Back to MDCX Roi Comparisons >> See Annual MDCX Return On Investment

Return On Investment MDCX's Ranking
Within:	No.
Industry	# 374
Sector	# 787
Overall	# 4430

Return On Investment Statistics
High	Average	Low
-1025.95 %	-2359.77 %	-3410.99 %
(Jun 30 2026)		(Mar 31 2026)

Financial Statements
Medicus Pharma Ltd's II. Quarter Investments	$ 16 Millions	MDCX's Balance sheet
Medicus Pharma Ltd's II. Quarter Income	$ -12 Millions	Quarterly MDCX's Income Statement
MDCX's Income by Division		See MDCX's Income by Division

MDCX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	0	3	0	0	0
Y / Y Investment Growth	-93.17 %	-	-	-	-
Net Income in Millions	-35	-11	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-15536.1 %	-333.93 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDCX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDCX's Competitors
Subscribers only: Roi for Medicus Pharma Ltd's Suppliers
Subscribers only: Return On Investment for MDCX's Customers

Other Ratios
MDCX's Roa	MDCX's Inventory Turnover Ratio	MDCX's Growth Rates	MDCX's Dividend Statistics
	MDCX's Profitability Ratios	MDCX's Asset Turnover Ratio	MDCX's Dividend Growth
MDCX's Roe	MDCX's Valuation Ratios	MDCX's Financial Strength Ratios	MDCX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-12T06:27:28+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.